Our research probes the mechanistic role of HSP90B1 in regulating the PI3K/Akt/mTOR pathway, a key downstream effector of EGFR signaling implicated in the oncogenesis of various cancers [31, 32]. This evidence concerns the gene HSP90B1 and cancer.